Compare Koninklijke Philips NV (PHG) vs Texas Instruments Incorporated (TXN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Koninklijke Philips NV vs Texas Instruments Incorporated — how do they compare? Koninklijke Philips NV trades at $26.3 (market cap $25.89B), while Texas Instruments Incorporated trades at $285.3 (market cap $265.11B). The key difference: Texas Instruments Incorporated is far larger — about 10.2× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| PHG | TXN | |
|---|---|---|
Market Cap | $25.89B | $265.11B |
Sector | Health | Technology |
52-Week High | $32.91 | $332.35 |
52-Week Low | $25.02 | $153.33 |
Enterprise Value | $32.18B | $274.06B |
Dividend Yield | 3.81% | 1.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PHG trades at $26.58, down 1.37% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported net income of $895 million in 2025, a significant recovery from prior losses, with a net margin of 5.5%. Recent FDA clearances for medical devices and AI integrations highlight ongoing innovation. Cash flow from operations remains positive at $1.17 billion for 2025, though net cash flow declined to $403 million.
The outlook is mixed: analyst consensus is neutral with 59% hold ratings, reflecting caution despite recent profitability improvements. Key risks include high debt levels, with debt-to-asset ratio at 25.44% in 2025, and competitive pressures in health technology. Upside potential hinges on execution of AI-driven growth initiatives and margin expansion, as noted in Seeking Alpha analysis on 2026-05-20.
Texas Instruments (TXN) trades at $294.19, up 3.56% today, with a mixed technical signal leaning bearish. The stock shows strong profitability with a 29.11% net margin and 32.18% ROE, but valuation ratios like a P/E of 49.79 appear elevated. Recent Q1 2026 earnings beat expectations, while Q3 and Q4 2025 missed. The company maintains solid cash flow and recently announced a CFO transition effective August 2026.
The outlook balances strong fundamentals against high valuation and technical headwinds. Upside potential exists from the $314.27 consensus price target and AI-driven demand, but risks include competitive pressures and debt levels rising to 40.61% of assets. Investor sentiment is cautiously optimistic with 47.69% of analysts rating Buy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →About Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
Read more on TXN →
